A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2026-06-03		NCT07623616

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kyowa Kirin Co., Ltd.	15

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chiba Aoba Municipal Hospital	Chiba	Japan	1
Dokkyo Medical University Hospital	Tochigi	Japan	2
Gifu Municipal Hospital	Gifu	Japan	4
Hyogo Medical University Hospital	Hyōgo	Japan	1
Imamura General Hospital	Kagoshima	Japan	1
Jichi Medical University Hospital	Tochigi	Japan	5
Jichi Medical University Saitama Medical Center	Saitama	Japan	1
Kanagawa Cancer Center	Kanagawa	Japan	5
Kansai Medical University Hospital	Osaka	Japan	3
Keio University Hospital	Tokyo	Japan	8
Kurashiki Central Hospital	Okayama	Japan	3
Kyoto University Hospital	Kyoto	Japan	15
Matsumoto National Hospital	Nagano	Japan	1
Mito Medical Center	Ibaraki	Japan	1
Nagasaki University Hospital	Nagasaki	Japan	5
Nippon Medical School hospital	Tokyo	Japan	7
Okayama University Hospital	Okayama	Japan	21
Osaka Metropolitan University Hospital	Osaka	Japan	10
Tohoku University Hospital	Miyagi	Japan	3
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital	Tokyo	Japan	4

Clinical trials